文献速递骨肌技术与安全MR

影像组学在软组织肉瘤诊断、分级及治疗反应评估中的系统综述与Meta分析

Radiomics in Diagnosis, Grading, and Treatment Response Assessment of Soft Tissue Sarcomas: A Systematic Review and Meta-analysis.
PubMed 文献 · Acad Radiol · 2024-05-21

该系统综述与Meta分析纳入24篇文章(其中21篇用于Meta分析),评估影像组学在软组织肉瘤诊断、分级和治疗反应评估中的价值,以组织病理学诊断为参考标准。诊断汇总敏感度84%、特异度63%、AUC 0.93;分级敏感度84%、特异度73%、AUC 0.91;治疗反应评估敏感度83%、特异度67%、AUC 0.87。作者认为影像组学具有潜力,但强调需要标准化和前瞻性试验。

要点

  • 诊断软组织肉瘤:影像组学汇总敏感度84%(95%CI 80-87)、特异度63%(95%CI 56-70)、AUC 0.93。
  • 分级评估:汇总敏感度84%(95%CI 82-87)、特异度73%(95%CI 68-77)、AUC 0.91。
  • 治疗反应评估:汇总敏感度83%(95%CI 67-94)、特异度67%(95%CI 59-74)、AUC 0.87。

核心结论

  • 影像组学在软组织肉瘤的诊断、分级和治疗反应评估中展现出潜力,但作者强调需要标准化和前瞻性试验。

研究设计与样本

  • 诊断准确性系统综述与Meta分析,检索579条唯一标题和摘要,纳入24篇文章进行系统综述,其中21篇用于Meta分析;影像组学应用多种MRI序列和AI分类器,以组织病理学诊断为参考标准;统计分析采用随机效应模型和Deeks漏斗图不对称检验。

诊断标准与关键数值

  • 诊断:汇总敏感度84%(95%CI 80-87),汇总特异度63%(95%CI 56-70),AUC 0.93。
  • 分级:汇总敏感度84%(95%CI 82-87),汇总特异度73%(95%CI 68-77),AUC 0.91。
  • 治疗反应评估:汇总敏感度83%(95%CI 67-94),汇总特异度67%(95%CI 59-74),AUC 0.87。

临床应用与阅片要点

  • 作者认为影像组学在软组织肉瘤诊断、分级和治疗反应评估中具有潜力,并强调需要标准化和前瞻性试验。

局限性

  • 作者在结论中强调需要标准化和前瞻性试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To evaluate radiomics in soft tissue sarcomas (STSs) for diagnostic accuracy, grading, and treatment response assessment, with a focus on clinical relevance.

METHODS: In this diagnostic accuracy study, radiomics was applied using multiple MRI sequences and AI classifiers, with histopathological diagnosis as the reference standard. Statistical analysis involved meta-analysis, random-effects model, and Deeks' funnel plot asymmetry test.

RESULTS: Among 579 unique titles and abstracts, 24 articles were included in the systematic review, with 21 used for meta-analysis. Radiomics demonstrated a pooled sensitivity of 84% (95% CI: 80-87) and specificity of 63% (95% CI: 56-70), AUC of 0.93 for diagnosis, sensitivity of 84% (95% CI: 82-87) and specificity of 73% (95% CI: 68-77), AUC of 0.91 for grading, and sensitivity of 83% (95% CI: 67-94) and specificity of 67% (95% CI: 59-74), AUC of 0.87 for treatment response assessment.

CONCLUSION: Radiomics exhibits potential for accurate diagnosis, grading, and treatment response assessment in STSs, emphasizing the need for standardization and prospective trials.

CLINICAL RELEVANCE STATEMENT: Radiomics offers precise tools for STS diagnosis, grading, and treatment response assessment, with implications for optimizing patient care and treatment strategies in this complex malignancy.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Zhu N, Meng X, Wang Z, et al. Radiomics in Diagnosis, Grading, and Treatment Response Assessment of Soft Tissue Sarcomas: A Systematic Review and Meta-analysis. Acad Radiol. 2024. PMID: 38772802. doi:10.1016/j.acra.2024.03.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。